06:50 EST Cidara Therapeutics (CDTX) jumps 104% to $216.26 after Merck (MRK) buyout offer
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CDTX:
- Merck close to deal to acquire Cidara Therapeutics, FT reports
- Cidara Therapeutics’ Earnings Call Highlights CD388 Progress
- Cidara Therapeutics price target raised to $145 from $137 at RBC Capital
- Positive Outlook on Cidara Therapeutics: Progress in CD388 Flu Program and Strategic Trial Advancements
- Cidara Therapeutics Advances CD388 with Phase 3 Expansion